| Replagal |
Human |
agalsidase alfa |
agalsidase alfa |
EMEA/H/C/000369 |
Takeda Pharmaceuticals International AG Ireland Branch |
2001/08/03
|
Authorised |
| Fabrazyme |
Human |
agalsidase beta |
agalsidase beta |
EMEA/H/C/000370 |
Sanofi B.V. |
2001/08/03
|
Authorised |
| INOmax |
Human |
nitric oxide |
nitric oxide |
EMEA/H/C/000337 |
Linde Healthcare AB |
2001/08/01
|
Authorised |
| Liprolog |
Human |
insulin lispro |
insulin lispro |
EMEA/H/C/000393 |
Eli Lilly Nederland B.V. |
2001/08/01
|
Authorised |
| Ceprotin |
Human |
human protein C |
human protein C |
EMEA/H/C/000334 |
Takeda Manufacturing Austria AG |
2001/07/16
|
Authorised |
| DepoCyte |
Human |
cytarabine |
cytarabine |
EMEA/H/C/000317 |
Pacira Limited |
2001/07/11
|
Withdrawn |
| Ketek |
Human |
telithromycin |
telithromycin |
EMEA/H/C/000354 |
Aventis Pharma S.A. |
2001/07/09
|
Withdrawn |
| Levviax |
Human |
telithromycin |
telithromycin |
EMEA/H/C/000355 |
Aventis Pharma S.A. |
2001/07/09
|
Withdrawn |
| MabCampath |
Human |
alemtuzumab |
alemtuzumab |
EMEA/H/C/000353 |
Genzyme Europe B.V. |
2001/07/06
|
Withdrawn |
| Nonafact |
Human |
human coagulation factor IX |
human coagulation factor IX |
EMEA/H/C/000348 |
Sanquin Plasma Products B.V. |
2001/07/03
|
Withdrawn |
| Aranesp |
Human |
darbepoetin alfa |
darbepoetin alfa |
EMEA/H/C/000332 |
Amgen Europe B.V. |
2001/06/08
|
Authorised |
| Nespo |
Human |
darbepoetin alfa |
darbepoetin alfa |
EMEA/H/C/000333 |
Dompé Biotec S.p.A. |
2001/06/08
|
Withdrawn |
| Uprima |
Human |
apomorphine |
apomorphine hydrochloride |
EMEA/H/C/000327 |
Abbott Laboratories Ltd. |
2001/05/28
|
Withdrawn |
| Taluvian |
Human |
apomorphine |
apomorphine hydrochloride |
EMEA/H/C/000386 |
Abbott S.r.l. |
2001/05/28
|
Withdrawn |
| Ixense |
Human |
apomorphine |
apomorphine hydrochloride |
EMEA/H/C/000328 |
Takeda Europe R Centre Ltd. |
2001/05/28
|
Withdrawn |
| Osigraft |
Human |
eptotermin alfa |
eptotermin alfa |
EMEA/H/C/000293 |
Olympus Biotech International Limited |
2001/05/17
|
Withdrawn |
| HBVaxPro |
Human |
hepatitis B vaccine (recombinant DNA) |
hepatitis B, recombinant surface antigen |
EMEA/H/C/000373 |
Merck Sharp & Dohme B.V. |
2001/04/27
|
Authorised |
| Starlix |
Human |
nateglinide |
nateglinide |
EMEA/H/C/000335 |
Novartis Europharm Limited |
2001/04/03
|
Withdrawn |
| Trazec |
Human |
nateglinide |
nateglinide |
EMEA/H/C/000383 |
Novartis Europharm Ltd. |
2001/04/03
|
Lapsed |
| Targretin |
Human |
bexarotene |
bexarotene |
EMEA/H/C/000326 |
H.A.C. Pharma |
2001/03/29
|
Authorised |